Last 12 months
Inside the activity.
0 purchase rows · 4 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 4 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 14, 2024 Filed Apr 8, 2024 23:30 UTC |
Rodriguez JavierSee Remarks
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-044858 · tm2411220-2_4seq1.xml · nonDerivative · entry 1 Rodriguez Javier · CIK 0001847919 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 6,434 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| March 14, 2024 Filed Apr 8, 2024 23:30 UTC |
Yocca FrankChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-24-044857 · tm2411220-1_4seq1.xml · derivative · entry 4 Yocca Frank · CIK 0001733272 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 4,169 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F4 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F4 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| March 14, 2024 Filed Apr 8, 2024 23:30 UTC |
Yocca FrankChief Scientific Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-24-044857 · tm2411220-1_4seq1.xml · nonDerivative · entry 1 Yocca Frank · CIK 0001733272 · Chief Scientific Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 11,580 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:55 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 2,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126924 · tm2333119-4_4seq1.xml · derivative · entry 4 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,485 Underlying: Common Stock · 2,609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F3 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:55 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionCommon Stock | 2,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-126924 · tm2333119-4_4seq1.xml · nonDerivative · entry 1 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:47 UTC |
O'Neill VincentChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126916 · tm2333119-1_4seq1.xml · derivative · entry 2 O'Neill Vincent · CIK 0001672718 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,690 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 16:47 UTC |
O'Neill VincentChief Medical Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-126916 · tm2333119-1_4seq1.xml · nonDerivative · entry 1 O'Neill Vincent · CIK 0001672718 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,802 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:52 UTC |
Steinhart Richard IChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126921 · tm2333119-2_4seq1.xml · derivative · entry 2 Steinhart Richard I · CIK 0001293789 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,690 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:52 UTC |
Steinhart Richard IChief Financial Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-126921 · tm2333119-2_4seq1.xml · nonDerivative · entry 1 Steinhart Richard I · CIK 0001293789 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,063 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:57 UTC |
Yocca FrankChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126926 · tm2333119-5_4seq1.xml · derivative · entry 2 Yocca Frank · CIK 0001733272 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,690 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:57 UTC |
Yocca FrankChief Scientific Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-126926 · tm2333119-5_4seq1.xml · nonDerivative · entry 1 Yocca Frank · CIK 0001733272 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,059 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:54 UTC |
Rodriguez JavierSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-126923 · tm2333119-3_4seq1.xml · derivative · entry 2 Rodriguez Javier · CIK 0001847919 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,690 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:54 UTC |
Rodriguez JavierSee Remarks
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-126923 · tm2333119-3_4seq1.xml · nonDerivative · entry 1 Rodriguez Javier · CIK 0001847919 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,913 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:47 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 2,610 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-101635 · tm2326350d1_4seq1.xml · derivative · entry 3 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,094 Underlying: Common Stock · 2,610 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F3 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F3 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:47 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionCommon Stock | 2,610 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-101635 · tm2326350d1_4seq1.xml · nonDerivative · entry 1 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,613 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · balance_after: Represents adjustment in number of shares to correct an inadvertent error in the number of shares directly owned following the reported transaction in the Form 4 filed on May 24, 2023 and Form 4s filed thereafter. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 16:47 UTC |
O'Neill VincentChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-101637 · tm2326350-4_4seq1.xml · derivative · entry 2 O'Neill Vincent · CIK 0001672718 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,211 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 16:47 UTC |
O'Neill VincentChief Medical Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-101637 · tm2326350-4_4seq1.xml · nonDerivative · entry 1 O'Neill Vincent · CIK 0001672718 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,281 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:49 UTC |
Steinhart Richard IChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-101640 · tm2326350-5_4seq1.xml · derivative · entry 2 Steinhart Richard I · CIK 0001293789 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,211 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:49 UTC |
Steinhart Richard IChief Financial Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-101640 · tm2326350-5_4seq1.xml · nonDerivative · entry 1 Steinhart Richard I · CIK 0001293789 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,542 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:49 UTC |
Yocca FrankChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-101641 · tm2326350-3_4seq1.xml · derivative · entry 2 Yocca Frank · CIK 0001733272 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,211 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:49 UTC |
Yocca FrankChief Scientific Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-101641 · tm2326350-3_4seq1.xml · nonDerivative · entry 1 Yocca Frank · CIK 0001733272 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,538 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:48 UTC |
Rodriguez JavierSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-101639 · tm2326350d2_4seq1.xml · derivative · entry 2 Rodriguez Javier · CIK 0001847919 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,211 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 20:48 UTC |
Rodriguez JavierSee Remarks
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-101639 · tm2326350d2_4seq1.xml · nonDerivative · entry 1 Rodriguez Javier · CIK 0001847919 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 20:59 UTC |
MILLER MICHAEL PATRICKDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0001104659-23-075868 · tm2319786-2_4seq1.xml · derivative · entry 1 MILLER MICHAEL PATRICK · CIK 0001236514 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-06-26 F1 · derivative.exercise_date: The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 17:01 UTC |
MUELLER PETERDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0001104659-23-075872 · tm2319786-4_4seq1.xml · derivative · entry 1 MUELLER PETER · CIK 0001256126 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-06-26 F1 · derivative.exercise_date: The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 16:56 UTC |
Votruba MichalDirector
|
OtherStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0001104659-23-075863 · tm2319786-3_4seq1.xml · derivative · entry 2 Votruba Michal · CIK 0001653967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 17,000 shares Expires 2033-06-26 F1 · kind: The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein. F2 · derivative.exercise_date: The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 16:56 UTC |
Votruba MichalDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0001104659-23-075863 · tm2319786-3_4seq1.xml · derivative · entry 1 Votruba Michal · CIK 0001653967 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-06-26 F1 · kind: The Reporting Person immediately and automatically assigned these stock options to RSJ Investments SICAV a.s. acting in respect of its sub-fund RSJ Gradus podfund ("RSJ") pursuant to the policies of RSJ regarding stock ownership by its employees, as documented by an Agreement between the Reporting Person and RSJ. The Reporting Person does not beneficially own any of the securities reported herein. F2 · derivative.exercise_date: The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 21:02 UTC |
Bray JuneDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0001104659-23-075875 · tm2319786-6_4seq1.xml · derivative · entry 1 Bray June · CIK 0001845487 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-06-26 F1 · derivative.exercise_date: The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date. Read SEC document |
| June 26, 2023 Filed Jun 28, 2023 20:58 UTC |
Laumas SandeepDirector
|
GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $17.52 | $0.00 |
DisclosureSEC source: 0001104659-23-075866 · tm2319786-5_4seq1.xml · derivative · entry 1 Laumas Sandeep · CIK 0001721664 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,000 Underlying: Common Stock · 17,000 shares Expires 2033-06-26 F1 · derivative.exercise_date: The option shall vest and become exercisable on the earlier of the first anniversary of the date of grant or the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of grant, in either case, subject to the Reporting Person's continuing in service as a non-employee director through such vesting date. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · derivative · entry 12 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 294,000 Underlying: Common Stock · 30,000 shares Expires 2027-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
SaleCommon Stock | 747 | $21.89 | $16,351.83 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · nonDerivative · entry 8 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,903 F2 · kind: The sales reported in this Form 4 were effected pursuant to a plan that complies with Rule 10b5-1 entered into on August 31, 2022. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
SaleCommon Stock | 4,266 | $20.90 | $89,159.40 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · nonDerivative · entry 7 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,650 F2 · kind: The sales reported in this Form 4 were effected pursuant to a plan that complies with Rule 10b5-1 entered into on August 31, 2022. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.59 to $21.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
SaleCommon Stock | 24,987 | $20.01 | $499,989.87 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · nonDerivative · entry 6 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,916 F2 · kind: The sales reported in this Form 4 were effected pursuant to a plan that complies with Rule 10b5-1 entered into on August 31, 2022. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.57 to $20.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 16, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionCommon Stock | 30,000 | $0.41 | $12,300.00 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · nonDerivative · entry 5 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 30,000 | $0.00 Strike: $0.41 | $0.00 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · derivative · entry 11 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 324,000 Underlying: Common Stock · 30,000 shares Expires 2027-08-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
SaleCommon Stock | 8,012 | $21.90 | $175,462.80 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · nonDerivative · entry 4 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,903 F2 · kind: The sales reported in this Form 4 were effected pursuant to a plan that complies with Rule 10b5-1 entered into on August 31, 2022. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.83 to $22.03, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
SaleCommon Stock | 21,988 | $21.41 | $470,763.08 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · nonDerivative · entry 3 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,915 F2 · kind: The sales reported in this Form 4 were effected pursuant to a plan that complies with Rule 10b5-1 entered into on August 31, 2022. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.83 to $21.825, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionCommon Stock | 30,000 | $0.41 | $12,300.00 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · nonDerivative · entry 2 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionRestricted Stock Units · Derivative | 2,609 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · derivative · entry 10 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 28,704 Underlying: Common Stock · 2,609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F7 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F7 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 41,750 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:40 UTC |
Mehta VimalDirector · CEO and President
|
Exercise / conversionCommon Stock | 2,609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-072396 · tm2319006-2_4seq1.xml · nonDerivative · entry 1 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,903 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 18:36 UTC |
O'Neill VincentChief Medical Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-072395 · tm2319006-1_4seq1.xml · derivative · entry 2 O'Neill Vincent · CIK 0001672718 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,732 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 18:36 UTC |
O'Neill VincentChief Medical Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-072395 · tm2319006-1_4seq1.xml · nonDerivative · entry 1 O'Neill Vincent · CIK 0001672718 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,760 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:42 UTC |
Steinhart Richard IChief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-072397 · tm2319006-3_4seq1.xml · derivative · entry 2 Steinhart Richard I · CIK 0001293789 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,732 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:42 UTC |
Steinhart Richard IChief Financial Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-072397 · tm2319006-3_4seq1.xml · nonDerivative · entry 1 Steinhart Richard I · CIK 0001293789 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,021 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:46 UTC |
Rodriguez JavierSee Remarks
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-072399 · tm2319006-5_4seq1.xml · derivative · entry 2 Rodriguez Javier · CIK 0001847919 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,732 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:46 UTC |
Rodriguez JavierSee Remarks
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-072399 · tm2319006-5_4seq1.xml · nonDerivative · entry 1 Rodriguez Javier · CIK 0001847919 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,871 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:44 UTC |
Yocca FrankChief Scientific Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 521 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-072398 · tm2319006-4_4seq1.xml · derivative · entry 2 Yocca Frank · CIK 0001733272 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,732 Underlying: Common Stock · 521 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. F2 · derivative.exercise_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. F2 · derivative.expiration_date: On March 14, 2022, the Reporting Person was granted 8,337 RSUs, vesting as to 25% of the total number of RSUs on the first anniversary of March 14, 2022 and as to 6.25% of the total number of RSUs at the end of each successive three-month period thereafter, subject to the Reporting Person's continuous employment with the Issuer through the relevant vesting dates. Read SEC document |
| June 14, 2023 Filed Jun 16, 2023 22:44 UTC |
Yocca FrankChief Scientific Officer
|
Exercise / conversionCommon Stock | 521 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001104659-23-072398 · tm2319006-4_4seq1.xml · nonDerivative · entry 1 Yocca Frank · CIK 0001733272 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,017 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock. Read SEC document |
| May 22, 2023 Filed May 24, 2023 20:37 UTC |
Mehta VimalDirector · CEO and President
|
SaleCommon Stock | 6,500 | $25.79 | $167,640.85 |
DisclosureSEC source: 0001104659-23-064163 · tm2316022-4_4seq1.xml · nonDerivative · entry 1 Mehta Vimal · CIK 0001733369 · Director · CEO and President 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 37,294 F1 · kind: The sales reported in this Form 4 were effected pursuant to a plan that complies with Rule 10b5-1 entered into on August 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.45 to $26.14, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 15, 2023 Filed May 17, 2023 00:32 UTC |
Steinhart Richard IChief Financial Officer
|
SaleCommon Stock | 5,000 | $27.17 | $135,863.50 |
DisclosureSEC source: 0001104659-23-061538 · tm2316022-2_4seq1.xml · nonDerivative · entry 2 Steinhart Richard I · CIK 0001293789 · Chief Financial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,500 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 23, 2022. F3 · price: The price reported is a weighted average price. The securities were sold in multiple transactions at per share prices ranging from $26.84 to $27.63. The Reporting Person undertakes to provide upon request the Securities and Exchange Commission staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities sold at each separate price within the range set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.